Home/Filings/4/0001104659-21-153339
4//SEC Filing

Hughes Mark A. 4

Accession 0001104659-21-153339

CIK 0001833769other

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 9:46 PM ET

Size

18.8 KB

Accession

0001104659-21-153339

Insider Transaction Report

Form 4
Period: 2021-12-22
Hughes Mark A.
Chief Operating Officer
Transactions
  • Award

    Class A Common Stock

    2021-12-22+19,61519,615 total
  • Award

    Stock Option (right to buy)

    2021-12-22+21,32221,322 total
    Exercise: $3.76Exp: 2029-07-01Class A Common Stock (21,322 underlying)
  • Award

    Stock Option (right to buy)

    2021-12-22+54,03754,037 total
    Exercise: $3.76Exp: 2030-01-18Class A Common Stock (54,037 underlying)
  • Award

    Stock Option (right to buy)

    2021-12-22+4,9124,912 total
    Exercise: $3.27Exp: 2031-04-14Class A Common Stock (4,912 underlying)
  • Award

    Stock Option (right to buy)

    2021-12-22+3,2753,275 total
    Exercise: $3.76Exp: 2030-01-18Class A Common Stock (3,275 underlying)
  • Award

    Stock Option (right to buy)

    2021-12-22+60,58760,587 total
    Exercise: $3.27Exp: 2031-04-14Class A Common Stock (60,587 underlying)
Footnotes (12)
  • [F1]In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Optimus Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub I"), Optimus Merger Sub II, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub II"), Hyperfine, Inc.,
  • [F10]Received in connection with the Mergers in exchange for a stock option to acquire 15,000 shares of Hyperfine common stock for $1.07 per share.
  • [F11]The shares underlying this option vest in 48 equal monthly installments beginning on October 31, 2020, subject to Mr. Hughes's continued service through the applicable vesting date.
  • [F12]Received in connection with the Mergers in exchange for a stock option to acquire 185,000 shares of Hyperfine common stock for $1.07 per share.
  • [F2]a Delaware corporation ("Hyperfine"), and Liminal Sciences, Inc., a Delaware corporation ("Liminal"), pursuant to which Merger Sub I merged with and into Hyperfine (the "Hyperfine Merger"), with Hyperfine surviving the Hyperfine Merger as a wholly owned subsidiary of HealthCor, and Merger Sub II merged with and into Liminal (the "Liminal Merger" and, together with the Hyperfine Merger, the "Mergers"), with Liminal surviving the Liminal Merger as a wholly owned subsidiary of HealthCor (which changed its name to "Hyperfine, Inc.", the "Issuer"), these shares were received in exchange for 59,894 shares of Hyperfine common stock.
  • [F3]The shares underlying this option vest as to 25% on September 30, 2020, with the remainder vesting in equal monthly installments, over the following three years, subject to Mr. Hughes's continued service through the applicable vesting date.
  • [F4]Received in connection with the Mergers in exchange for a stock option to acquire 65,106 shares of Hyperfine common stock for $1.23 per share.
  • [F5]The shares underlying this option vest as to 25% on December 31, 2020, with the remainder vesting in equal monthly installments, over the following three years, subject to Mr. Hughes's continued service through the applicable vesting date.
  • [F6]Received in connection with the Mergers in exchange for a stock option to acquire 165,000 shares of Hyperfine common stock for $1.23 per share.
  • [F7]The shares underlying this option vest as to 25% on December 31, 2020, with the remainder vesting in equal monthly installments, over the following three years, subject to Mr. Hughes's continued service through the applicable vesting date.
  • [F8]Received in connection with the Mergers in exchange for a stock option to acquire 10,000 shares of Hyperfine common stock for $1.23 per share.
  • [F9]The shares underlying this option vest in 48 equal monthly installments beginning on October 31, 2020, subject to Mr. Hughes's continued service through the applicable vesting date.

Issuer

Hyperfine, Inc.

CIK 0001833769

Entity typeother

Related Parties

1
  • filerCIK 0001898765

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 9:46 PM ET
Size
18.8 KB